Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2004; 92(05): 1157-1158
DOI: 10.1055/s-0037-1614295
DOI: 10.1055/s-0037-1614295
Case Report
Liver transplantation for type 1 primary hyperoxaluria as a cure for combined thrombophilia
Authors
Further Information
Publication History
Received
15 June 2004
Accepted after revision
08 August 2004
Publication Date:
14 December 2017 (online)
-
References
- 1 Cochat P. Primary hyperoxaluria type 1. Kidney Int 1999; 55: 2533-47.
- 2 Scheinman JI, Alexander M, Campbell ED. et al. Transplantation for primary hyperoxaluria in the USA. Nephrol Dial Transplant 1995; 10 (Suppl. 08) 42-6.
- 3 Astarcioglu I, Karademir S, Gulay H. et al. Primary hyperoxaluria: simultaneous combined liver and kidney transplantation from a living related donor. Liver Transpl 2003; 09: 433-6.
- 4 Beutler E, Lichtman MA, Coller BS. et al. Inherited deficiencies of coagulation factors. In: Williams Hematology. McGraw-Hill; 2001: 1617-38.
- 5 Emmerich J, Rosendaal FR, Cattaneo M. et al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism – pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Thromb Haemost 2001; 86: 809-16.
- 6 Tan HP, Markowitz JS, Maley WR. et al. Successful liver transplantation in a patient with Budd-Chiari syndrome caused by homozygous factor V Leiden. Liver Transpl 2000; 06: 654-6.
- 7 Willems M, Sterneck M, Langer F. et al. Recurrent deep-vein thrombosis based on homozygous factor V Leiden mutation acquired after liver transplantation. Liver Transpl 2003; 09: 870-3.
- 8 Hirshfield G, Collier JD, Brown K. et al. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transpl Surg 1998; 04: 58-61.
- 9 Favaloro EJ, Orsag I, Bukuya M. et al. A 9-year retrospective assessment of laboratory testing for activated protein C resistance: evolution of a novel approach to thrombophilia investigations. Pathology 2002; 34: 348-55.
- 10 Gruenewald M, Germowitz A, Beneke H. et al. Coagulation factor II activity determination is not useful as a screening tool for the G20210A prothrombin gene allele. Thromb Haemost 2000; 84: 141-2.
- 11 Poort SR, Rosendaal FR, Reitsma PH. et al. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.